Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)
5
3
3
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 5 trials
0%
0 trials in Phase 3/4
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (5)
ALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stool
Study on the Use of Traditional Chinese Medicine Diagnostic Tools to Assist in Identifying the Clinical Characteristics of Inflammatory Bowel Disease and Research on Metabolic Plastids of Tongue Coating
Prevalence of Helicobacter Pylori on Patients With Chronic Inflammatory Bowel Disease (IBD) at the CHU of Guadeloupe
Molecular Inflammation Board at the Center for Personalized Medicine
Spiritual Needs of European Patients With Inflammatory Bowel Disease and Their Caregivers